Physician profile
Kathleen Donovan
NPI 1295715514
$16,239.20
in general payments reported to CMS, 2019-2025
34 companies · $2,494 in 2025
The $2,494 reported for 2025 was more than what 75% of Allergy providers received nationally (typical 2025 total: $1,129).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,115 · 2020: $1,428 · 2021: $2,123 · 2022: $2,496 · 2023: $3,141 · 2024: $2,442 · 2025: $2,494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,979 · Education: $98.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,978.72 |
| Education | $98.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $3,173.21 | 2019-2025 | Dupixent |
| Genzyme Corporation | $2,526.61 | 2019-2025 | |
| Glaxosmithkline, LLC. | $2,168.20 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,540.17 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Pfizer INC. | $975.71 | 2019-2025 | |
| Genentech USA, INC. | $623.08 | 2019-2025 | Xolair |
| Takeda Pharmaceuticals U.S.A., INC. | $600.57 | 2020-2025 | Glassia, Cuvitru, Hyqvia |
| Amgen INC. | $590.27 | 2020-2025 | Tezspire, Actimmune |
| Csl Behring | $555.74 | 2019-2025 | Hizentra, Andembry, Haegarda |
| Biocryst US Sales Co., LLC | $542.24 | 2021-2025 | Orladeyo |
| Alk-Abello, INC | $363.46 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $332.30 | 2019-2022 | |
| Pharming Healthcare, INC. | $331.37 | 2020-2023 | Ruconest |
| Kaleo, INC. | $299.25 | 2019-2024 | Auvi-Q |
| Grifols USA, LLC | $276.49 | 2019-2023 | Xembify |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $252.92 | 2019-2024 | |
| Incyte Corporation | $158.94 | 2021-2023 | Opzelura |
| Horizon Therapeutics Plc | $146.84 | 2019-2023 | Actimmune |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.32 | 2019-2023 | Stiolto Respimat |
| Novartis Pharmaceuticals Corporation | $98.91 | 2025 | |
| Blueprint Medicines Corporation | $91.14 | 2022-2024 | |
| Uswm, LLC | $90.42 | 2021 | |
| Octapharma USA, INC. | $68.67 | 2022-2025 | Panzyga, Cutaquig |
| Shire North American Group INC | $59.54 | 2019 | |
| Aimmune Therapeutics, INC. | $45.90 | 2021 | |
| Phadia US INC. | $40.69 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $39.72 | 2021-2023 | |
| Biocryst Pharmaceuticals, INC. | $32.11 | 2020 | |
| Organon LLC | $31.49 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $19.89 | 2025 | Neffy |
| Circassia INC. | $17.82 | 2019 | |
| Covis Pharma Gmbh | $16.23 | 2022 | |
| Galderma Laboratories, L.P. | $14.47 | 2025 | Nemluvio |
| Verona Pharma, INC. | $13.51 | 2025 | Ohtuvayre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Donovan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.